Innovating Works
Mostrando 1 al 20 de 35 resultados
ENDOMIX: Understanding how endocrine disruptors and chemical mixtures of concern target the immune system to... EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un HORIZON EUROPE: HORIZON-HLTH-2023-ENVHLTH-02 The ENDOMIX project addresses the urgent need to understand the true impact of endocrine disrupting chemicals (EDCs) on human health in orde...
2023-11-13 - 2027-12-31 | Financiado
ODELIA: Open Consortium for Decentralized Medical Artificial Intelligence EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 ArtifArtificial Intelligence (AI) will revolutionize healthcare as its diagnostic performance approaches that of clinical experts. In partic...
2023-01-01 - 2027-12-31 | Financiado
Med-IPUT: Medical Integrated Photonic Ultrasound Transducer EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un HORIZON EUROPE: HORIZON-CL4-2022-DIGITAL-EMERGING-01 The multi-sensing 'Medical Integrated Photonic Ultrasound Transducer' (MED-IPUT) project will develop a high-resolution, high-quality, recyc...
2022-12-02 - 2026-06-30 | Financiado
HyperProbe: Transforming brain surgery by advancing functional-guided neuronavigational imaging EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 In recent years, through the advancement of imaging technologies (such as MRI, PET, CT, among others) clinical localisation of lesions of th...
2022-07-08 - 2027-09-30 | Financiado
CHAIMELEON: Accelerating the lab to market transition of AI tools for cancer management EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-SC1-FA-DTS-2018-2020 CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. A...
2020-06-02 - 2025-02-28 | Financiado
EuCanImage: A European Cancer Image Platform Linked to Biological and Health Data for Next Generation Artificial... EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-SC1-FA-DTS-2018-2020 The goal of EuCanImage is to build a highly secure, federated and large-scale European cancer imaging platform, with capabilities that will...
2020-05-29 - 2024-09-30 | Financiado
EURAMED rocc-n-roll: EURopeAn MEDical application and Radiation prOteCtion Concept strategic research agenda aNd ROadmap... EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: NFRP-2019-2020 The 3-year EURAMED rocc-n-roll project aims to propose an integrated and coordinated European approach to research and innovation in medical...
2020-05-14 - 2023-08-31 | Financiado
SINFONIA: Radiation risk appraisal for detrimental effects from medical exposure during management of patients... EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: NFRP-2019-2020 Reinforced risk appraisal of medical exposure is needed due to an extensive use of ionising radiation for diagnosis and therapy. The main ob...
2020-05-14 - 2024-08-31 | Financiado
AlternativesToGd: Hyperpolarised MR technologies and molecular probes as alternatives for conventional metal containin... EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-FETOPEN-2018-2020 Recently, the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA) recommended suspension and warning labels for Ga...
2019-09-24 - 2023-09-30 | Financiado
MEDIRAD: Implications of Medical Low Dose Radiation Exposure EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: NFRP-2016-2017 MEDIRAD aims to enhance the scientific bases and clinical practice of radiation protection (RP) in the medical field and thereby addresses t...
2017-05-26 - 2022-02-28 | Financiado
SOLUS: Smart optical and ultrasound diagnostics of breast cancer EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-ICT-2016-2017 SOLUS is a trans-disciplinary 54-month project bringing together 9 partners: industries (4), academic and clinical institutions from 5 count...
2016-11-03 - 2021-10-31 | Financiado
EURO-CAS: EU eHealth Interoperability Conformity Assessment Scheme EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: H2020-SC1-2016-2017 EURO-CAS, European eHealth Interoperability Conformity Assessment Scheme aims at maintaining and developing the adoption and take-up of test...
2016-10-05 - 2018-11-30 | Financiado
HYPMED: Digital Hybrid Breast PET MRI for Enhanced Diagnosis of Breast Cancer EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: H2020-PHC-2014-2015 Breast cancer represents a leading cause of cancer death in women and a major socio-economic issue. With currently available methods, early...
2015-12-09 - 2022-06-30 | Financiado
GLINT: GlucoCEST Imaging of Neoplastic Tumours EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-PHC-2014-2015 Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usu...
2015-12-09 - 2019-12-31 | Financiado
CoSTREAM: Common mechanisms and pathways in Stroke and Alzheimer s disease. EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG participó en un H2020: H2020-PHC-2014-2015 Common mechanisms and pathways in Stroke and Alzheimer's disease. It has long been recognized that stroke and (Alzheimer’s Disease) AD often...
2015-12-09 - 2021-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.